相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
BRCA1 gene: function and deficiency
Miho Takaoka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Mechanisms of PARP inhibitor sensitivity and resistance
Alan D. D'Andrea
DNA REPAIR (2018)
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models
Hyoung Kim et al.
CLINICAL CANCER RESEARCH (2017)
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
Stephanie A. Yazinski et al.
GENES & DEVELOPMENT (2017)
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines
Kyle R. Roell et al.
FRONTIERS IN PHARMACOLOGY (2017)
DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy
Laura Carrassa et al.
CANCER TREATMENT REVIEWS (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Jonathan A. Ledermann et al.
LANCET ONCOLOGY (2016)
Replication fork stability confers chemoresistance in BRCA-deficient cells (vol 535, pg 382, 2016)
Arnab Ray Chaudhuri et al.
NATURE (2016)
Targeting WEE1 Kinase in Cancer
Christopher J. Matheson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Dose-Response Analysis Using R
Christian Ritz et al.
PLOS ONE (2015)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
Petar Jelinic et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Ashok R. Venkitaraman
SCIENCE (2014)
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Catherine J. Huntoon et al.
CANCER RESEARCH (2013)
ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA
Luis Ignacio Toledo et al.
CELL (2013)
Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer Utility of a Histology-Based Referral Strategy
Kasmintan A. Schrader et al.
OBSTETRICS AND GYNECOLOGY (2012)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair
Peter J. O'Donovan et al.
CARCINOGENESIS (2010)
Chk1 promotes replication fork progression by controlling replication initiation
Eva Petermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The multiple facets of the intra-S checkpoint
Beata Grallert et al.
CELL CYCLE (2008)
ATR: an essential regulator of genome integrity
Karlene A. Cimprich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Functional characterization of a novel BRCA1-Null ovarian cancer cell line in response to ionizing radiation
Christiana DelloRusso et al.
MOLECULAR CANCER RESEARCH (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer
Susanne Malander et al.
GYNECOLOGIC ONCOLOGY (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance
EJ Brown et al.
GENES & DEVELOPMENT (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
